Cytokinetics Inc (CYTK) Stock Price Today
CoreWeave draws opposing bets from top investors Tepper and Soros amid AI cloud growth and debt concerns
In Q2 2026, David Tepper's Appaloosa fund initiated a significant new position in CoreWeave, an AI cloud infrastructure company, while George Soros's fund held puts against the same stock but reduced their bearish exposure during the quarter. CoreWea...
Nuclear stocks drop as AI revenue doubts and rising long-term rates hit valuations
Nuclear energy stocks like Oklo, Constellation Energy, and NuScale Power fell sharply due to concerns over AI-related capital expenditure and a spike in long-term Treasury yields to a 19-year high. AI companies reported lower-than-expected revenue fo...
Palvella advances QTORIN for skin disorders with positive Phase 3 data and $230M funding boost
Palvella is progressing its drug QTORIN, targeting microcystic lymphatic malformations and other skin diseases, supported by positive Phase 3 SELVA trial results. The company is leveraging a repeatable regulatory and commercial platform to expand QTO...
Law firm investigates BellRing Brands officers for possible shareholder duty breaches
Halper Sadeh LLC is investigating whether certain officers and directors of BellRing Brands, Inc. breached their fiduciary duties to shareholders. Long-term BellRing stockholders may seek corporate governance reforms, financial incentives, or other r...
Apple shares rise 1.5% as Nasdaq dips, seen as safe tech amid huge off-balance-sheet AI spending by rivals
Apple shares closed up 1.5% at $310.03 while the Nasdaq-100 index fell 2%, making Apple the top performer among major tech stocks. A Wall Street Journal report revealed that big tech firms like Alphabet, Meta, and Microsoft have committed nearly $3 t...
Globant cuts 2026 revenue forecast, triggering stock drop and securities investigation.
Globant initially forecasted 2026 revenue growth but later revised its outlook to a slight year-over-year decline, causing a sharp drop in its stock price. This reversal prompted Levi & Korsinsky to investigate potential securities law violations on ...
Bicara Therapeutics advances cancer drug trial with strong cash to fund operations through 2029
Bicara Therapeutics is progressing its Phase 3 trial of ficerafusp alfa for head and neck cancer, expecting interim results by mid-2027 that could support accelerated approval. The company holds nearly $500 million in cash and securities, funding ope...
Fintech, leveraged ETFs, and AI stocks plunge amid outlook cuts and sector sell-offs
Klarna shares dropped 22.81% after cutting its earnings outlook and announcing leadership changes, raising investor concerns. Fabrinet's stock fell 19.38% despite strong quarterly results due to a broader sell-off in AI infrastructure stocks. Leverag...
LG Display develops FLiPP, a new FMM-less OLED tech boosting brightness, lifespan, and efficiency.
LG Display has created FLiPP, a new OLED manufacturing method that eliminates the need for the traditional fine metal mask (FMM) process. This innovation increases display brightness by 1.6 times, extends lifespan by 2.4 times, and reduces power cons...
Asia Pacific Petroleum Conference 2026 to address energy market volatility and supply challenges
The 42nd Asia Pacific Petroleum Conference (APPEC) will be held from September 7-10, 2026, in Singapore, gathering 1,500 global energy leaders to discuss critical issues like crude supply, energy security, and market resilience amid unprecedented vol...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.